Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 14(1): 15275, 2024 07 03.
Article in English | MEDLINE | ID: mdl-38961231

ABSTRACT

Providing adequate counseling on mode of delivery after induction of labor (IOL) is of utmost importance. Various AI algorithms have been developed for this purpose, but rely on maternal-fetal data, not including ultrasound (US) imaging. We used retrospectively collected clinical data from 808 subjects submitted to IOL, totaling 2024 US images, to train AI models to predict vaginal delivery (VD) and cesarean section (CS) outcomes after IOL. The best overall model used only clinical data (F1-score: 0.736; positive predictive value (PPV): 0.734). The imaging models employed fetal head, abdomen and femur US images, showing limited discriminative results. The best model used femur images (F1-score: 0.594; PPV: 0.580). Consequently, we constructed ensemble models to test whether US imaging could enhance the clinical data model. The best ensemble model included clinical data and US femur images (F1-score: 0.689; PPV: 0.693), presenting a false positive and false negative interesting trade-off. The model accurately predicted CS on 4 additional cases, despite misclassifying 20 additional VD, resulting in a 6.0% decrease in average accuracy compared to the clinical data model. Hence, integrating US imaging into the latter model can be a new development in assisting mode of delivery counseling.


Subject(s)
Cesarean Section , Delivery, Obstetric , Labor, Induced , Ultrasonography, Prenatal , Humans , Female , Pregnancy , Ultrasonography, Prenatal/methods , Adult , Retrospective Studies , Fetus/diagnostic imaging , Algorithms
2.
J Gynecol Obstet Hum Reprod ; 47(8): 405-408, 2018 Oct.
Article in English | MEDLINE | ID: mdl-29981476

ABSTRACT

Immune thrombocytopenia (ITP) during pregnancy is an acquired autoimmune disease present in 1-2 of every 1000 pregnancies. Thrombopoietin (TPO)-mimetic drugs, such as eltrombopag, have been successfully used for treatment of ITP during pregnancy, but studies regarding its safety during gestation are lacking. A 33-year-old nulliparous woman with a history of chronic ITP, presented at the emergency department with petechiae, epistaxis, bruises, conjunctival effusions and a platelet count of 3×109/L at 25 weeks gestation. Her pregnancy had been uneventful until then. She was unresponsive to a therapeutic escalade of corticosteroids, azathioprine and intravenous immunoglobulin (IV Ig) so, at 27 weeks, eltrombopag was initiated, and analytical and clinical improvement was achieved. Labor was induced at 37 weeks due to preeclampsia, culminating in a vacuum-assisted vaginal delivery. A healthy female newborn weighing 2400g was born. After delivery, both had normal platelet counts and remained clinically stable through follow-up.


Subject(s)
Benzoates/pharmacology , Hydrazines/pharmacology , Pregnancy Complications, Hematologic/drug therapy , Purpura, Thrombocytopenic, Idiopathic/drug therapy , Pyrazoles/pharmacology , Receptors, Thrombopoietin/agonists , Adult , Benzoates/administration & dosage , Female , Humans , Hydrazines/administration & dosage , Live Birth , Pregnancy , Pyrazoles/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...